Liposome-mediated high-efficiency transfection of human endothelial cells

Journal of Vascular Research
S Kaiser, M Toborek

Abstract

Liposome-mediated transfection of endothelial cells provides a valuable experimental technique to study cellular gene expression and may also be adapted for gene therapy studies. However, the widely recognized disadvantage of liposome-mediated transfection is low efficiency. Therefore, studies were performed to optimize transfection techniques in human endothelial cells. The majority of the experiments were performed with primary cultures of human umbilical vein endothelial cells (HUVEC). In addition, selected experiments were performed using human brain microvascular endothelial cells and human dermal microvascular endothelial cells. To study transfection rates, HUVEC were transfected with the pGL3 vector, containing the luciferase reporter gene, complexed with several currently available liposomes, such as different Perfect Lipid (pFx) mixtures, DMRIE-C, or lipofectin. The optimal transfection rate was achieved in HUVEC transfected for 1.5 h with 5 microg/ml of DNA plasmid in the presence of 36 microg/ml of pFx-7. In addition, transfection with the VR-3301 vector encoding for human placental alkaline phosphatase revealed that, under the described conditions, transfection efficiency in HUVEC was approximately 32%. Transfection...Continue Reading

Citations

Mar 29, 2002·Journal of Biomedical Materials Research·Khalid N KaderRavi V Bellamkonda
Nov 17, 2006·Pharmaceutical Research·V P Torchilin
Jul 28, 2009·DNA and Cell Biology·Julien Yockell-LelièvreMarie Audette
Jan 12, 2010·Journal of Drug Targeting·Guoqin NiuJeffrey A Hughes
May 5, 2007·Expert Opinion on Biological Therapy·Stefanos TheoharisPeng H Tan
Dec 13, 2006·The Journal of Surgical Research·Shihe LiuF Charles Brunicardi
Dec 18, 2002·Journal of Neurochemistry·Michal ToborekAvindra Nath
Sep 30, 2005·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Karine BollérotThierry Jaffredo
Oct 9, 2007·International Journal of Radiation Oncology, Biology, Physics·Dorota GabryśChryso Kanthou
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Yong Woo LeeMichal Toborek
Jan 5, 2002·The American Journal of Clinical Nutrition·Michal ToborekBernhard Hennig
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Santhosh Chandar MaddilaSrujan Marepally

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
I AleksicP Barath
Biologicals : Journal of the International Association of Biological Standardization
Wen-Zhen LinWing-Tai Cheung
© 2021 Meta ULC. All rights reserved